PlasoRon Biotech

PlasoRon is a biotechnology company specializing in the development of high-sensitivity liquid biopsy platforms for early disease detection and monitoring. The company's core technology leverages proprietary plasmonic-enhanced sensing to profile extracellular vesicles, specifically exosomes, directly from blood samples. By identifying specific protein signatures on these vesicles, PlasoRon aims to provide non-invasive diagnostic solutions for various cancers and neurodegenerative disorders. Their platform offers a significant improvement in sensitivity and throughput compared to traditional exosome analysis methods, facilitating more precise patient stratification and treatment tracking.